Demayo, Bb Boy I .

HRN: 28-31-57  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/27/2025
01/03/2026
IV
40mg
Q24
PSNB
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines